Atropine Pharmaceutical Compositions

US10583132B2 · kind B2 · utility

Assignee

• NEUVANA, LLC · US

Inventors

• Navneet Puri · Lebanon, US
• Prem Sagar Akasapu · Edison, US
• Irfan A. Mohammed · Fremont, US
• Kumaresh Soppimath · Colts Neck Township, US
• Iouri V. Ilitchev

Key dates

• Filing date: Feb 20, 2019
• Grant date: Mar 10, 2020
• Expiry date: Feb 20, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P27/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The inventive subject matter is directed to compositions and methods for sterile and storage stable low-dose atropine formulations with improved stability. Most preferably, the compositions presented herein are substantially preservative free and exhibit less than 0.35% tropic acid from degradation of atropine. Advantageously, contemplated formulations are also substantially free of preservatives.